产品说明葡萄糖神经酰胺合酶YZ剂该产品包含在以下化合物库中:质量控制化学性质 CAS号 | 139974-41-7 | | |
别名 | DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol |
分子式 | C29H50N2O3 • HCl | 分子量 | 511.2 |
溶解性 | Soluble in DMSO | 储存条件 | Store at -20° |
实验操作 细胞实验[2]: |
细胞系 | |
溶解方法 | |
反应时间 | |
应用 | |
动物实验[3]: |
动物模型 | |
剂量 | |
注意事项 | |
References: |
产品描述DL-threo-PPMP (hydrochloride) is an inhibitor of glucosylceramide synthase [1].
Glucosylceramide synthase (GCS) is a pervasive enzyme inherent to intracellular ceramide metabolism. The enzyme has been involved in catalyzing the transfer of glucose to ceramide, which is the principle committed step in glycolipid biosynthesis. GCS has been involved in the cytotoxic response of cancer cells to chemotherapy. Glucosylceramide synthase-based sphingolipids have been identified as important mediators of a variety of cellular functions, including proliferation, differentiation, development, and cell-cell recognition [2].
DL-threo-PPMP was a ceramide analog. DL-threo-PPMP inhibited the activity of glucosylceramide synthase with an IC50 value between 2 and 20 μM. It has been used to study the role of glucosylceramide synthase in cell growth, apoptosis, and autophagy [1].
References:
[1] Lee L, Abe A, Shayman J A. Improved inhibitors of glucosylceramide synthase[J]. Journal of Biological Chemistry, 1999, 274(21): 14662-14669.
[2] Bleicher R J, Cabot M C. Glucosylceramide synthase and apoptosis[J]. Biochimica et biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2002, 1585(2): 172-178.
温馨提示:不可用于临床ZL。